一、急性淋巴细胞白血病 (一)诱导缓解:凡年龄在2～10岁男儿,初诊时血中白细胞<2×10~9/L(20000/mm~8),糖元染色(PAS)(+),免疫学属非T非B,形态学血片无幼稚淋巴细胞,骨髓分型不是L_3型,无纵膈肿大与中枢神经系统白血病者属标准危险组(标危组)。其中60%经过治疗缓解存活期>5年。其余急性淋巴细胞白血病人(包括成人急淋)都属高危组。 First, the acute lymphoblastic leukemia (A) induced remission: Where the age of 2 to 10-year-old man, the first visit of blood leukocytes <2 × 10 ~ 9 / L (20000 / mm ~ 8), glycogen staining (PAS) ), Immunology is non-T non-B, morphological blood cells without naive lymphocytes, bone marrow typing is not L_3 type, no mediastinal swelling and central nervous system leukemia are standard risk group (standard risk group). Of which 60% after treatment to ease the survival of> 5 years. The remaining acute lymphoblastic leukemia patients (including adult acute lymphoblastic) are high-risk group.